What they were paid
CRESCENT BIOPHARMA Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $44,652 | $0 | $106,923 | $0 | $151,575 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CRESCENT BIOPHARMA, INC. DEF 14A filed April 21, 2026, accession 0001628280-26-026282, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025CRESCENT BIOPHARMA pays directors a $40,000 cash retainer.
Committees
FY2025 · as the proxy prints themNominating/Governance (Chair)
The rest of the CRESCENT BIOPHARMA board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Alexandra Balcom | Independent Director | $140,466 |
| David Lubner | Independent Director | $294,991 |
| Jonathan Violin, Ph.D | Director | $474,301 |
| Joshua Brumm | Director | $0 |
| Susan Moran, M.D., MSCE | Independent Director | $136,964 |
The full CRESCENT BIOPHARMA compensation record
free company briefThis page is one director within CRESCENT BIOPHARMA's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat